In re Lidoderm Antitrust Litigation
Case # | 14-md-02521 |
---|---|
Case Name | In re Lidoderm Antitrust Litigation |
Jurisdiction | US District Court for N.D. CA |
Summary | Defendant (Endo Pharmaceuticals) manufactures and retails a lidocaine patch 5% (used to treat complications from shingles) under the brand name Lidoderm. Plaintiffs allege that Defendant paid a competitor not to produce a lower-priced generic version of this patch. As a result of this payoff, Defendant was able to keep the price of the patches artificially high and consumers were forced to pay a higher price for the product than they would in a truly competitive market. |
Final Approval Date | 09/20/2018 |
Result |
|
Dismissal of Last Appeal | N/A |
Attachments | Docket Report.pdf Third Consolidated Amended Complaint.pdf Preliminary Approval Order.pdf Final Approval Order.pdf Order Granting Attorneys Fees.pdf |
Added to Index | |
Last Updated |
Objection of Pamela Sweeney
Objectors | Pamela Sweeney |
---|---|
Signers | Pamela Sweeney |
Attorneys | |
Summary |
Class Counsel motioned for expedited discovery of Objector Sweeney, which was granted by the Court. |
Attachments | Objection of Pamela Sweeney.pdf Motion for Expedited Discovery of Objector Sweeney.pdf Order Granting Motion for Discovery of Objector Sweeney.pdf Order Withdrawing Sweeney Appeal.pdf |
Added to Index | |
Last Updated |